Related Experiment Videos
Generalized lymphangiomatosis presenting as cardiomegaly
Yi-Ling Chen1, Chin-Cheng Lee, Ming-Lun Yeh
1Department of Pediatrics, Shin Kong Wu Ho-Su Memorial Hospital, Taipei, Taiwan.
Summary
Generalized lymphangiomatosis in an infant was treated with surgery and interferon (IFN) alpha-2b. This approach showed no recurrence over two years, suggesting IFN alpha-2b as a potential treatment.
Area of Science:
- Pediatric Oncology
- Vascular Anomalies
- Immunotherapy
Background:
- Lymphangioma is a benign proliferation of lymphatic tissue.
- Generalized lymphangiomatosis is a rare condition affecting multiple organs.
Observation:
- An 8-month-old infant presented with tachypnea, fever, and a mediastinal mass causing cardiomegaly.
- The mass extended to the thymus, lung, and spleen, diagnosed as lymphangiomatosis via biopsy.
- Initial treatments including fluid drainage and parenteral nutrition were ineffective.
Findings:
- Surgical resection of the mediastinal mass and spleen was performed.
- Subcutaneous interferon (IFN) alpha-2b was administered for 3 months post-surgery.
- No recurrence was observed during a 2-year follow-up period.
Implications:
- Interferon (IFN) alpha-2b shows promise as an alternative treatment for generalized lymphangiomatosis.
- This case highlights a successful multimodal approach for a rare pediatric condition.
- Further research into immunotherapy for lymphangiomatosis is warranted.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy IV: Restrictive Cardiomyopathy
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy VI: Nursing Management
Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...